Belongs to

• GSK Faculty

Types of Work

["2023"]

[[["Meeting Abstracts",875],["Journal Articles",565],["Reviews",72],["Research Letters",38],["Editorials",29],["Correspondences",25],["Miscellaneous",17],["Book Sections",11],["Guidelines",7],["Conference Papers",4]]]

[1643]

Popular keywords

• adult
• aged
• article
• controlled study
• female
• human
• humans
• major clinical study
• male
• overall survival

Recent Works

1. Belantamab mafodotin in patients with relapsed/refractory multiple myeloma: A real-world experience

   Journal Article

   Hultcrantz, M.; Derkach, A.; Hassoun, H.; Korde, N.; MacLachlan, K.; Mailankody, S.; Patel, D.; Shah, U. A.; Tan, C. R.; Chung, D. J.; more...
   Blood Neoplasia (2025)

   Fulltext@MSK | Save
2. Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma

   Correspondence

   Sebastian, T.; Rajeeve, S.; Farzana, T.; Firestone, R.; Jurgens, E.; Miller, K.; Costa, B.; Lesokhin, A.; Tan, C.; Shah, G.; more...
   Blood Cancer Journal (2025)

   Fulltext@MSK | Save
3. Prevalence and development of cachexia before and after diagnosis of non-small cell lung cancer

   Journal Article

   Gilmore, L. A.; Willmann, J.; Olaechea, S.; Gilmore, B. W.; Dee, E. C.; Rao, M.; Gannavarapu, B. S.; Venkateswaran, S.; Alvarez, C. M.; Ahn, C.; more...
   American Journal of Clinical Oncology (2025)

   Fulltext@MSK | Save